Browse our collection of papers in
Marks and Spencer

C/F/815. Use of CAPM in measuring investment opportunities of M&S and GSK

WORDS:
2250
DATE:
2010
PRICE:
29.99 GBP

The paper looks at the corporate and international financial measures used to minimise risks associated with investment decisions examining Marks and Spencer (M&S) and GlaxoSmithKline (GSK) as investment opportunities. The use of financial measurement tools includes the calculation and comparison of Beta for the stocks of both companies using the Capital Asset Pricing Model (CAPM).

 

KEYWORDS: Marks and Spencer, M&S, GlaxoSmithKline, GSK, Investment Decisions, Capital Asset Pricing Model, CAMP,

 
Other Papers On: Investment Appraisals
Other Papers On: GlaxoSmithKline (GSK)
Other Papers On: Marks and Spencer